본문 바로가기

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q1KCI Q1
저널
Cancer Research and Treatment57(2) · pp.312 · 2025
피인용
Web of Science 96Scopus 103KCI 13
FWCI (Scopus)
22.3
JCR IF
JCR 2024 3.8
ISSN
1598-2998

저자

  1. Park, Eun Hye제1저자National Cancer Control Institute, National Cancer Center, Goyang, Korea
  2. Jung, Kyu Won교신저자National Cancer Control Institute, National Cancer Center, Goyang, Korea
  3. Park, Nam JuNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  4. Kang, Mee JooNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  5. Hwa Yun, E.National Cancer Control Institute, National Cancer Center, Goyang, Korea
  6. Kim, Hye JinNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  7. Kim, Jeong EunNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  8. Kong, Hyun JooNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  9. Choi, Kui SonNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  10. Yang, Han KwangNational Cancer Control Institute, National Cancer Center, Goyang, Korea
  11. 김창훈(Busan Cancer Registry, Pusan National University Hospital)
  12. Yoo, Cheolin(Ulsan Cancer Registry, Ulsan University Hospital)
  13. Kim, Yong Dae(Chungbuk Cancer Registry, Chungbuk National University Hospital)
  14. Kim, Young Taek(Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital)
  15. Park, Kyung Ki(Jeju Cancer Registry, Jeju National University Hospital)
  16. Youm, Jung Ho(Chungbuk Cancer Registry, Chungbuk National University Hospital)
  17. Lim, Kyu Hyoung(Kangwon Cancer Registry, Kangwon National University Hospital)
  18. Shin, Ji Yeon(Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Hospital)
  19. Kweon, Sun Seog(Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital)
  20. Kim, Hwan Cheol(Incheon Cancer Registry, Inha University Hospital)
  21. Park, Ki Soo(Gyeongnam Cancer Registry, Gyeongsang National University Hospital)

초록

Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2022, with international comparisons. Materials and Methods Cancer incidence, survival, and prevalence rates were calculated using the Korea National Cancer Incidence Database (1999-2022), with survival follow-up until December 31, 2023. Mortality data obtained from Statistics Korea, while international comparisons were based on GLOBOCAN data. Results In 2022, 282,047 newly diagnosed cancer cases (age-standardized rate [ASR], 287.0 per 100,000) and 83,378 deaths from cancer (ASR, 65.7 per 100,000) were reported. The proportion of localized-stage cancers increased from 45.6% in 2005 to 50.9% in 2022. Stomach, colorectal, and breast cancer showed increased localized-stage diagnoses by 18.1, 18.5, and 9.9 percentage points, respectively. Compared to 2001-2005, the 5-year relative survival (2018-2022) increased by 20.4 percentage points for stomach cancer, 7.6 for colorectal cancer, and 5.6 for breast cancer. Korea had the lowest cancer mortality among countries with similar incidence rates and the lowest mortality-to-incidence (M/I) ratios for these cancers. The 5-year relative survival (2018-2022) was 72.9%, contributing to over 2.59 million prevalent cases in 2022. Conclusion Since the launch of the National Cancer Screening Program in 2002, early detection has improved, increasing the diagnosis of localized-stage cancers and survival rates. Korea recorded the lowest M/I ratio among major comparison countries, demonstrating the effectiveness of its National Cancer Control Program.

키워드

IncidenceKoreaMortalityNeoplasmsPrevalenceSurvival

식별자

Scopus EID
2-s2.0-105003138691
WoS UID
001473930500002
KCI
ART003193079